Peter Harper

11.5k citations
139 papers · 7.7k · 3 hit papers · h-index 45

Impact in

  • Oncology top 0.5%
    • Colorectal Cancer Treatments and Studies
    • Pancreatic and Hepatic Oncology Research
    • Lung Cancer Research Studies
    • Cancer Treatment and Pharmacology
    • Gastric Cancer Management and Outcomes
    • Lung Cancer Treatments and Mutations

Papers in

    • Lung Cancer Research Studies 27
    • Colorectal Cancer Treatments and Studies 13
    • Cancer Treatment and Pharmacology 13
    • Lung Cancer Treatments and Mutations 21
    • Lung Cancer Diagnosis and Treatment 11
    • Gastric Cancer Management and Outcomes 10

Peter Harper

136 papers receiving 7.5k citations

Peter Harper's Hit Papers

Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer 2009 · 604 citations
6040+9+19Years since publication200400600

Peers

Peter Harper
Comparison fields: 5 of 126
  • Oncology 3.8k
  • Pulmonary and Respiratory Medicine 2.4k
  • Reproductive Medicine 493
  • Gastroenterology 244
  • Cancer Research 623
Replace A.T. van Oosterom with:
A.T. van Oosterom Netherlands
Irene Floriani Italy
Pierre Kerbrat France
Vittorio Gebbia Italy
Ashley E. Winkler United States
Bohuslav Melichar Czechia
Scott Wadler United States
Jee Hyun Kim South Korea
Howard S. Höchster United States
Harry S. Wieand United States
Peter Harper relative to A.T. van Oosterom Netherlands A.T. van Oosterom's profile →
Citations per field
00.5×1.5×2.3×
A.T. van Oosterom · 1×
Citations per year

Countries citing papers authored by Peter Harper

Since Specialization
Citations

This map shows the geographic impact of Peter Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Harper more than expected).

Fields of papers citing papers by Peter Harper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Harper. The network helps show where Peter Harper may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Harper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Harper Line = papers co-authored together Peter Harper links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
Hit paper breakdown →
1997691
2
Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
Hit paper breakdown →
2009604
3
Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
Hit paper breakdown →
2009502
4 2002368
5 1994320
6 2004313
7 2009266
8 2002249
9 1999219
10 2003174
11 1996163
12 2013141
13 1986139
14 2006125
15 2004121
16 2005121
17 1995116
18 1984104
19 2002103
20 199697

About Peter Harper

Peter Harper is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Epidemiology, having authored 139 papers that have together received 7.7k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (27 papers), Lung Cancer Treatments and Mutations (21 papers), Colorectal Cancer Treatments and Studies (13 papers), Neuroendocrine Tumor Research Advances (13 papers), Cancer Treatment and Pharmacology (13 papers), Lung Cancer Diagnosis and Treatment (11 papers), Gastric Cancer Management and Outcomes (10 papers) and Esophageal Cancer Research and Treatment (10 papers). The work is most often cited by research in Oncology (3.8k citations), Pulmonary and Respiratory Medicine (2.4k citations), Reproductive Medicine (493 citations), Gastroenterology (244 citations) and Cancer Research (623 citations). Peter Harper has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include David Cunningham, David S. Riddick, Allan B. Okey, Tamas Hickish, A. Norman, Timothy Iveson, Stephen Spiro, Juan W. Valle, Janine Mansi and M. Nicolson. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Annals of Oncology, British Journal of Cancer and Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact